- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06787365
Questionnaire for the Assessment of Risk Factors Associated with Endometriosis in Adolescent Women with Endometriosis
Questionnaire for the Assessment of Risk Factors Associated with Endometriosis in Adolescent Women Diagnosed with Endometriosis
A number of risk factors that may be associated with endometriosis in adolescents (medical history and symptoms) are reported in the literature, but no overall estimate of disease risk has been developed.
Providing a tool for assessing risk factors associated with endometriosis in adolescents by estimating disease risk could aid the clinician in diagnosis and reduce diagnostic delay
Study Overview
Status
Conditions
Detailed Description
Although more than 60% of adult women with endometriosis report that their painful symptoms appeared before the age of 20, early diagnosis, particularly in adolescent girls, is still a challenge for doctors. The reasons for this delay include inadequate knowledge of the disease among healthcare professionals, the social and health normalisation of menstrual pain, and the peculiar aspects of the disease in adolescent patients. The adolescent patient with endometriosis presents particular anamnestic, familial and personal risk factors, as well as peculiar symptoms such as non-specific abdominal pain, acyclic pelvic pain, gastrointestinal symptoms, migraine, in addition to those classically reported in adulthood.
It may therefore be useful to identify a predictive model of the onset of endometriosis based on the risk factors currently recognised in the literature (anamnestic data) and on the results of a questionnaire to be submitted to adult women (aged between 20 and 50 years), with endometriosis (group 1) and without a diagnosis of endometriosis (group 2), concerning symptoms experienced in adolescence
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Simona Del Forno, MD
- Phone Number: +390512143494
- Email: simona.delforno@aosp.bo.it
Study Contact Backup
- Name: Roberto Palermo, MD
- Email: roberto.palermo3@studio.unibo.it
Study Locations
-
-
-
Bologna, Italy, 40138
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
-
Contact:
- Simona Del Forno, MD
- Phone Number: +390512143494
- Email: simona.delforno@aosp.bo.it
-
Contact:
- Simona Del Forno, MD
-
Siena, Italy, 53100
- Azienda ospedaliero-universitaria Senese
-
Contact:
- Lucia Lazzeri, MD
- Phone Number: +393346887383
- Email: lazzeri13@unisi.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Women of childbearing age between 20 and 50 years
- Clinical and ultrasound diagnosis of endometriosis for the study group and exclusion of endometriosis for the control group (examination and ultrasound performed according to the IDEA study criteria)
- Acquisition of informed consent for participation in the study and processing of personal data
Exclusion Criteria:
- Women suffering from other conditions responsible for pelvic pain (uterine fibromatosis, current or previous pelvic inflammatory disease, ovarian cysts of a non-endometriotic nature, irritable bowel syndrome, inflammatory bowel disease, interstitial cystitis)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Study group
Patients with endometriosis
|
|
Control group
Patients without endometriosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Predictive model of endometriosis onset risk
Time Frame: During the first visit after enrollment
|
Predictive model of the occurrence of endometriosis based on the risk factors currently recognised in the literature (anamnestic data) and the results of a questionnaire consists of 28 multiple-choice questions, concerning symptoms experienced in adolescence
|
During the first visit after enrollment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Simona Del Forno, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- QuestionENDO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.